Current Practices in the Management of Antithrombotic Therapy During the Periendoscopic Period for Patients With Cardiovascular Disease

Access this Article

Search this Article

Author(s)

    • Ono Satoshi
    • Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo
    • Saito Itaru
    • Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo
    • Ikeda Yuichi
    • Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo
    • Fujishiro Mitsuhiro
    • Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo|Department of Endoscopy and Endoscopic Surgery, Graduate School of Medicine, The University of Tokyo
    • Komuro Issei
    • Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo
    • Koike Kazuhiko
    • Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo

Abstract

<p>The management of antithrombotics during the periendoscopic period is traditionally represented as a doubleedged sword for cardiologists and endoscopists. Appropriate administration prevents thromboembolic events, whereas excessive administration provokes bleeding events. Therefore, cardiologists and endoscopists must consider the risks of bleeding and thromboembolism in individual cases, before deciding whether to continue antithrombotic use. Several guidelines exist concerning antithrombotic management in Asian and Western countries. These guidelines generally classify procedural bleeding risk and thromboembolic risk into high risk and low risk groups and recommend that the two risks be weighed when managing a given patient. Moreover, they generally do not recommend interrupting antithrombotics during the periendoscopic period unless absolutely necessary; however, the details surrounding this point differ among the guidelines after several revisions. In this review, we describe the present state, problems, and future perspectives concerning the management of antithrombotics in patients with cardiovascular disease undergoing gastrointestinal endoscopy.</p>

Journal

  • International Heart Journal

    International Heart Journal 57(5), 530-534, 2016

    International Heart Journal Association

Codes

  • NII Article ID (NAID)
    130005266608
  • Text Lang
    ENG
  • ISSN
    1349-2365
  • Data Source
    J-STAGE 
Page Top